Viewing Study NCT01413451


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2025-12-25 @ 9:35 PM
Study NCT ID: NCT01413451
Status: TERMINATED
Last Update Posted: 2019-12-17
First Post: 2011-08-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Amatuximab for High Mesothelin Cancers
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module